Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers
By facilitating the crucial transition from “cold” to “hot” tumors, nanotechnology offers promising potential to amplify antitumor immunity and may contribute to improving clinical outcomes in esophageal cancer.